Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect
出版年份 2015 全文链接
标题
Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect
作者
关键词
-
出版物
DRUG DELIVERY
Volume -, Issue -, Pages 1-6
出版商
Informa UK Limited
发表日期
2015-06-16
DOI
10.3109/10717544.2015.1055619
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Smac Therapeutic Peptide Nanoparticles Inducing Apoptosis of Cancer Cells for Combination Chemotherapy with Doxorubicin
- (2015) Mingxing Li et al. ACS Applied Materials & Interfaces
- An overview of doxorubicin formulations in cancer therapy
- (2015) Sangeeta Rivankar Journal of Cancer Research and Therapeutics
- Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer
- (2014) Shixian Lv et al. BIOMATERIALS
- A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles
- (2014) Yan Wang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicityin vitro
- (2014) Yuwei Duan et al. DRUG DELIVERY
- Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment
- (2014) Tianshi Feng et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data
- (2014) Slavomira Doktorovova et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer
- (2014) Corey J. Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment
- (2014) Chia-Wei Su et al. Nanomedicine
- Can nanomedicines kill cancer stem cells?
- (2013) Yi Zhao et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid
- (2013) Tongyuan Lin et al. DRUG DELIVERY
- Studies on lactoferrin nanoparticles of gambogic acid for oral delivery
- (2013) Zhen-Hai Zhang et al. DRUG DELIVERY
- Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art
- (2013) S. Weber et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect
- (2013) Heshu Rahman et al. International Journal of Nanomedicine
- Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA
- (2013) Oleh Taratula et al. JOURNAL OF CONTROLLED RELEASE
- Nanostructured lipid carriers system: Recent advances in drug delivery
- (2012) Md Asif Iqbal et al. JOURNAL OF DRUG TARGETING
- Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
- (2011) Hai Wang et al. BIOMATERIALS
- Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration
- (2011) Vijaykumar Nekkanti et al. DRUG DELIVERY
- Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil
- (2010) Awesh K. Yadav et al. DRUG DELIVERY
- Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends
- (2009) Alvaro Moreno-Aspitia et al. CLINICAL THERAPEUTICS
- Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
- (2008) Martine J. Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started